The Market

The world-wide addressable market for pain monitoring is approximately $3.3 billion dollars (capital and disposables) annually. Considering the declaration of new pain management standards (“pain is the fifth vital sign”), the increasing awareness of pain monitoring, and increasing consumption of medical services by the aging population in developed countries, this market is expected to experience high growth.

Medasense’s target markets are hospitals, medical facilities, and R&D institutions. The main target market segment includes medical facilities that provide care to patients who are unable to communicate, for example: in operating rooms, intensive care units, and recovery rooms. Medasense’s secondary target market segments include pain clinics, oncology wards, geriatric wards, research institutions, and pharmaceutical and medical device companies developing pain-related products.

Medasense intends to sell stand-alone pain monitoring systems to medical facilities and OEM systems to manufactures of patient-monitoring devices. Medasense’s system includes both capital equipment and disposable sensor kits.

News

September, 2011:
Medasense Biometrics chosen to present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011

September, 2011:
Results of Medasense supported research were presented at "Pain in Europe VII", the 7th Congress of the European Federation of International Association for the Study of Pain Chapters

August, 2011:
Medasense Biometrics technology is featured in a newspaper article “Feel its pain: why the healthcare system doesn’t have a standard for measuring pain?” by Gali Weinreb, Globes, August 27th, 2011

June, 2011:
Medasense Biometrics has appeared on "The Landes Shortlist of Promising Israeli Technologies", by C. Wylie, Cell Cycle, Vol. 10, pp. 1887-1881.

May 2011:
Medasense to present at ILSI- Biomed Israel 2011 (Monday, May 23, 18:10 – 18:30)

December 2010:
OHV and Dr. Shmuel Cabilly invest in Medasense Biometrics

November 2010:
Results of Medasense supported research were presented on the annual conference of the Israel Pain Association

June 2010:
Medasense to present at Personalized Medicine World Conference 2010 Israel

December 2008:
Capital Point invests in Medasense Biometrics